Search

Author/Creator Pierce, Evangeline

1. 322 Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized, double-blinded, placebo-controlled phase 3 trials (ADvocate1 and ADvocate2). (25th January 2023)

Authors:
Blauvelt, Andrew; Thyssen, Jacob P; Guttman-Yassky, Emma ; Bieber, Thomas; Carrascosa, Jose Manuel; Simpson, Eric; Rosmarin, David ; Elmaraghy, Hany; Meskimen, Eric; Natalie, Chitra R; Liu, Zhuqing; Xu, Chenjia; Pierce, Evangeline; Morgan-Cox, MaryAnn; Silverberg, Jonathan I
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes. Issue 12 (4th November 2022)

Authors:
Simpson, Eric; Armstrong, April; Boguniewicz, Mark; Chiesa Fuxench, Zelma C.; Feely, Meghan; Pierce, Evangeline; Sun, Luna; Chen, Yun‐Fei; Angle, Robinette; Silverberg, Jonathan I.
Journal:
Dermatologic therapy
Issue:
Volume 35:Issue 12(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long‐term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate‐to‐severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE‐AD7. (20th January 2023)

Authors:
Silverberg, Jonathan I.; Simpson, Eric L.; Thyssen, Jacob Pontoppidan; Werfel, Thomas; Cardillo, Tracy E.; Colvin, Stephanie; Pierce, Evangeline; Chen, Yun‐Fei; Chen, Sherry; Eichenfield, Lawrence
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 5(2023)
Page Start:
1036
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial. (31st December 2023)

Authors:
Thyssen, Jacob P.; Werfel, Thomas; Barbarot, Sebastien; Hunter, Hamish J.A; Pierce, Evangeline; Sun, Luna; Cirri, Lisa; Buchanan, Andrew S.; Lu, Na; Wollenberg, Andreas
Journal:
Journal of dermatological treatment
Issue:
Volume 34:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Onset of Symptom Relief Reported in Daily Diaries of Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5). Issue 3 (May 2022)

Authors:
Rosmarin, David; Casillas, Marta; Chen, Sherry; Dawson, Zach; Pierce, Evangeline; Zhang, Hong; Bukhalo, Michael; Smith, Stacy
Journal:
Journal of cutaneous medicine and surgery
Issue:
Volume 26:Issue 3(2022)
Page Start:
262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials. (1st June 2022)

Authors:
Yosipovitch, Gil; Papp, Kim; Forman, Seth; Han, George; Waibel, Jill; Rueda, Maria J.; Sun, Luna; Chen, Yun‐Fei; Goldblum, Orin; Pierce, Evangeline; Silverberg, Jonathan I.
Journal:
British journal of dermatology
Issue:
Volume 186:Number 6(2022)
Page Start:
1047
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials. (21st April 2022)

Authors:
Yosipovitch, Gil; Papp, Kim; Forman, Seth; Han, George; Waibel, Jill; Rueda, Maria J.; Sun, Luna; Chen, Yun‐Fei; Goldblum, Orin; Pierce, Evangeline; Silverberg, Jonathan I.
Journal:
British journal of dermatology
Issue:
Volume 186:Number 6(2022)
Page Start:
1047
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗